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Abstract Human anaphylatoxin C3a had previously been shown 
to increase glycogenolysis in perfused rat liver and prostanoid 
formation in rat liver macrophages. Surprisingly, human C5a, 
which in other systems elicited stronger responses than C3a, did 
not increase glycogenolysis n perfused rat liver. Species incom- 
patibilities within the experimental system had been supposed to 
be the reason. The current study supports this hypothesis: (1) In 
rat liver macrophages that had been maintained in primary cul- 
ture for 72 h recombinant rat anaphylatoxin C5a in concentra- 
tions between 0.1 and 10 pg/ml increased the formation of throm- 
boxane A2, prostaglandin D2, E2 and F2,~ 6- to 12-fold over basal 
within 10 min. In contrast, human anaphylatoxin C5a did not 
increase prostanoid formation in rat Kupffer cells. (2) The in- 
crease in prostanoid formation by recombinant rat C5a was spe- 
cific. It was inhibited by a neutralizing monoclonal antibody. (3) 
In co-cultures of rat hepatocytes and rat Kupffer cells but not in 
hepatocyte mono-cultures recombinant rat C5a increased glyco- 
gen phosphorylase activity 3-fold over basal. This effect was 
inhibited by incubation of the co-cultures with 500 ttM acetylsal- 
icyclic acid. Thus, C5a generated either locally in the liver or 
systemically e.g. in the course of sepsis, may increase hepatic 
glycogenolysis by a prostanoid-mediated intercellular communi- 
cation between Kupffer cells and hepatocytes. 
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ylase activity in hepatocytes [7-11], these results uggested that 
anaphylatoxins stimulated hepatic glycogenolysis by an eicosa- 
noid-mediated intercellular communication between non- 
parenchymal cells and hepatocytes. Such a mechanism had 
been shown before for other mediators that reach the liver 
during inflammatory processes such as endotoxins [9], immune 
complexes [12], platelet activating factor [13-15] and also for 
zymosan [16], a yeast cell wall preparation. In line with this 
hypothesis human C3a increased prostanoid formation in iso- 
lated cultured rat Kupffer cells [17]. Surprisingly, human C5a, 
which in most systems elicits much stronger effects than C3a, 
did not increase glycogenolysis in perfused rat liver [3]. It was 
assumed that the lack of an effect of human C5a in perfused 
rat liver was due to a species incompatibility [3]. 
The aim of the current study was to corroborate the apparent 
species specificity of anaphylatoxin. C5a and, moreover, to 
demonstrate he C5a-elicited intercellular communication via 
prostanoids in Kupffer cell/hepatocyte co-cultures. It was 
found that recombinant rat C5a but not native human C5a 
increased prostanoid formation in cultured rat Kupffer cells 
and stimulated glycogen phosphorylase activity in rat Kupffer 
cell/hepatocyte co-cultures via an aspirin-inhibitable mecha- 
nism. 
2. Materials and methods 
1. Introduction 
Anaphylatoxins are small 74 to 78 amino acid proteins, that 
are generated as N-terminal cleavage products during the acti- 
vation of the complement factors C3, C4 and C5 either through 
the classical or the alternative pathway [1]. These anaphylatox- 
ins have previously been shown to activate glycogenolysis in
perfused rat liver: a low molecular mass fraction (10 to 17 kDa) 
of complement-activated rat serum [2] as well as purified 
human anaphylatoxin C3a [3] increased glucose output. This 
increase in hepatic glycogenolysis was attenuated by inhibitors 
of prostanoid synthesis and it was preceded by an elevation in 
prostaglandin and thromboxane overflow [2]. Since in liver 
prostanoids are formed almost exclusively in non-parenchymal 
liver cells, i.e. endothelial, Kupffer and Ito cells [4-6] and since 
prostaglandins F2=, E2 and D2 can activate glycogen phosphor- 
*Corresponding author. Fax: (49) (551) 395960. 
2.1. Materials 
All chemicals were of analytical grade and from commercial sources. 
The radioimmuno assays for TXBz, PGD:, PGFz~ and PGE: were 
bought from Amersham (38110 Braunschweig, Germany). Hydroluma 
was purchased from Baker (Deventer, The Netherlands), pronase from 
Merck AG (64293 Darmstadt, Germany) and collagenase and DNase 
from Boehringer (68305 Mannheim, Germany). Tissue culture dishes 
were obtained from Nunc (65203 Wiesbaden, Germany), Nycodenz 
from Life Technologies GmbH (76344 Eggenstein, Germany), Percoll 
from Pharmacia Biotech GmbH (79021 Freiburg, Germany), newborn 
calf serum (NCS) and bis-benzimide from Sigma Chemical Co. (82041 
Deisenhofen, Germany), RPMI 1640 from Biochrom KG (12247 Ber- 
lin, Germany) and M199 from Gibco BRL (76344 Eggenstein, Ger- 
many). The monoclonal antibody QD7 was generated against a C- 
terminal 20 amino acid peptide of C5a coupled to bovine serum albu- 
min (Sonntag G. and G6tze O., unpublished). 
2.2. Preparation of recomb&ant rat C5a and native human C5a 
Recombinant rat C5a was prepared by synthesis of a cDNA from rat 
liver RNA and a subsequent PCR using degenerate 5'and 3' primers 
that were designed according to sequence data published in the Swiss- 
Prot protein sequence data bank (accession o: P08650, ID: C05A_ 
RAT) [18]. The primers covered the amino acids 1 to 13 (Y-primer) and 
56 to 77 (3'-primer) of this sequence. The PCR-product was cloned into 
the bacterial expression vector pQE-30 (Qiagen, 40724, Hilden, Ger- 
many) with the additional N-terminal sequence MRGJHHHHHHGI 
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coded for by the polylinker. The recombinant protein was purified from 
bacterial lysates by Ni2+-chelate chromatography and refolded in a 
glutathion-containing renaturation buffer. Native human C5a was pre- 
pared from complement activated human serum as described elsewhere 
[19]. N-Acetyl-fl-D-glucosaminidase rel ase from human granulocytes 
was determined by an optical test [20]. 
2.3. Anima& 
Male Wistar rat (420 500 g for the preparation of Kupffer cells and 
200-250 g for the isolation of hepatocytes) were bought from Winkel- 
mann (33178 Borchen, Germany) and kept on a 12-h day-night rhythm 
(light from 07.00 to 19.00 h) with free access to water and a rat standard 
diet from Ssniff (59494 Soest, Germany) at least 2 weeks before the 
experiments. 
2.4. Kupffer cell preparation 
Non-parenchymal cells were prepared by a combined collagenase/ 
pronase perfusion [21,22]. Kupffer cells were then purified by Nycodenz 
density-gradient centrifugation and subsequent centrifugal elutriation 
using a Beckman JE-6 elutriation rotor in a J-21 Beckman centrifuge. 
2.5. Hepatocyte preparation 
Hepatocytes were isolated according to Meredith [23] without he use 
of collagenase as described previously [11]. The liver was perfused 
without recirculation via the portal vein with a CaZ+-free Krebs-Hense- 
leit buffer containing 15 mM glucose, 2 mM lactate, 0.2 mM pyruvate 
and 2 mM EDTA. Detritus was removed by two subsequent washing 
steps, sedimenting the viable hepatocytes at50 × g. Viable hepatocytes 
were further purified by centrifugation through a gradient with 58% 
Percoll. 
2.6. Kupffer cell culture 
Kupffer cells were plated (4 x 106/plate) on 3.5 cm tissue culture 
plates with or without collagen coating in RPMI 1640 in the presence 
of 1% penicillin]streptomycin and 30% neonatal calf serum for 72 h 
before the experiment. Medium was changed every 24 h. 
2. 7. HepatoeTte culture 
Hepatocytes were plated (5 x 105/plate) on collagen coated, 3.5 cm 
tissue culture plates in M 199 with 0.5 nM insulin, 1% penicillin]strepto- 
mycin and 30% NCS for 24 h before the experiment with a medium 
change after 4 h. 
2.8. Co-culture 
For co-culture with hepatocytes, Kupffer cells were seeded (3 x 106/ 
plate) on collagen coated, 3.5 cm culture plates in RPM! 1640 in the 
presence of 1% penicillin]streptomycin and 30% NCS for the first 48 
h. Medium was changed every 24 h. After 48 h, freshly prepared hepa- 
tocytes (5 x 105/plate) were plated on top of the Kupffer cells. Co- 
cultures were incubated in M199 with 0.5 nM insulin, 1% penicillin/ 
streptomycin and 30% NCS for another 24 h with one medium change 
after 4 h. 
2.9. Determination of prostanoid formation in KupJfer cells 
After 72 h cells were washed three times with Hank's balanced salt 
solution (137 mM NaC1, 5.4 mM KCI, 1.3 mM CaCI2, 0.8 mM MgCI2, 
4.2 mM NaHCO3, 0.34 mM NazPO4, 0.44 mM KH2PO4, 20 mM Hepes 
and 5 mM glucose, pH 7.4) to remove all residual serum and medium 
and then preincubated for 10 min at 37°C in 1.35 ml of the same buffer. 
Then the anaphylatoxins were added to the final concentrations indi- 
cated. Samples of 200/21 of the supernatant were taken at different times 
and frozen immediately in liquid nitrogen for the later determination 
of prostanoid concentrations. TXB2, PGDz, PGF2~ and PGE2 were 
determined in the cell supernatants without further purification by 
radioimmuno assay according to the instructions of the manufacturer. 
At the end of the experiment Kupffer cells were scraped off the dish for 
DNA determination in a fluorescence assay based on the intercalation 
of bis-benzimide into DNA [24]. 
2.10. Determination of glycogen phosphorylase activity in mono- and 
co-cultures 
Hepatocyte, Kupffer cell and hepatocyte/Kupffer c ll cultures were 
washed three times with Hepes buffered saline (20 mM Hepes, 120 mM 
NaC1, 4.8 mM KC1, 1.2 mM MgSO4, 1.2 mM KHzPO4, 2.5 mM CaCl2, 
5 mM glucose, 2 mM lactate and 0.2 mM pyruvate, pH 7.4). Cells were 
incubated for 10 min at 37°C in the same buffer. The medium was then 
discarded and replaced with 200/21 Hepes buffered saline containing 
recombinant rat C5a (final concentration 1 ~tg/ml), native human C5a 
(final concentration 1 /2g/ml) or noradrenaline (final concentration 
1/2M). After 2 min of incubation the buffer was removed and the plates 
were frozen in liquid nitrogen. To inhibit the cyclooxygenase (PGH- 
synthase) cell cultures were pretreated with 500/2M acetylsalicylic acid 
(ASA) in M199 30 min prior to the experiment. Control plates were 
incubated with M199 without ASA. Glycogen phosphorylase activity 
was determined with a standard assay [25]. 
3. Results and discussion 
3.1. Stimulation of  prostanoid formation by recombinant rat C5a 
in rat liver macrophages 
Recombinant  rat C5a increased prostanoid formation in cul- 
tured rat Kupffer cells rapidly and transiently (Fig. 1). After a 
single application of 10/2g recombinant rat C5a/ml the concen- 
trat ion of TXB2, PGD2, PGF2~ and PGE 2 increased over the 
following 5 min and remained almost constant for another 5 
rain thereafter. The maximal rate of prostanoid formation was 
reached at 1 rain, the first point taken (Fig. 1). Thus, the recom- 
binant rat C5a-mediated increase in prostanoid formation oc- 
curred sufficiently rapid to explain the increase in glycogenoly- 
sis in the perfused rat liver, which reached a maximum 2 min 
after the onset of infusion of complement activated serum [2]. 
Recombinant  rat C5a increased the formation of TXB2, 
PGD2, PGF2~ and PGE2 in a concentrat ion range between 0.1 
and 10/,tg/ml (Fig. 2). At 0.001/2g/ml recombinant rat C5a there 























Fig. 1. Time dependence of prostanoid formation elicited by recombi- 
nant rat C5a in rat liver macrophages. Rat Kupffer cells were isolated 
by a combined collagenase/pronase perfusion and purified by density 
gradient centrifugation a d centrifugal elutriation. They were cultured 
in RPMI medium containing 30% newborn calf serum for 72 h prior 
to the experiments. Medium was removed and replaced by Hanks' 
balanced salt solution. Cells were stimulated with 10/~g recombinant 
rat C5a/ml (final concentration). Aliquots of the supernatant were 
removed at the times indicated. The increase in eicosanoids over basal 
levels at 0 min, was determined by radioimmuno assay. Values are 
means _+ S.E.M. of 4 to 6 independent experiments. 
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Fig. 2. Dose dependence of prostanoid formation elicited by recombi- 
nant rat C5a in rat liver macrophages. Kupffer cells were isolated and 
cultured for 72 h as described in Fig. 1. Medium was then replaced by 
Hanks buffered salt solution. Cells were stimulated with the concentra- 
tions of recombinant rat C5a indicated. After 10 min supernatants were 
removed and the increase in eicosanoid concentration ver basal evels 
at 0 min, was determined by radioimmuno assay. Values are 
means + S.E.M. of 4 to 6 independent experiments. Statistics: Student's 
t-test for paired samples *P < 0.05. 
increase further up to 0.1 #g/ml. With the low recombinant rat 
C5a concentrations o significant increase in PGD2, PGF2~ or 
PGE2 formation was observed. The concentrations of recombi- 
nant rat C5a, that were needed to increase prostaglandin for- 
mation, were in the same range as the concentrations of human 
C3a, that were needed to increase prostanoid formation in rat 
Kupffer cells [17], and the concentrations of C5a, that were 
reached in human serum after complete activation of the com- 
plement system [19]. However, in other biological systems na- 
tive rat C5a elicited half maximal effects already at lower con- 
centrations. Thus, the EDs0 in a leukocyte chemotaxis assay 
was about 0.01/lg/ml [26], and the EDs0 for the contraction of 
guinea pig ileum was even as low as 0.3 ng/ml [26]. Most likely 
these variations in the biological efficiency of rat C5a reflect 
differences in the sensitivity of the cell types or tissues used in 
the biological assay systems. However, the recombinant rat C5a 
used in the current investigation was synthesized according to 
sequence data in the Swiss-Prot protein sequence data bank. It 
differed from the recently published sequence [26] in amino acid 
position 55 (K- > N), 63 (P- > H), 68 (Q- > E) and contained 
12 additional N-terminal residues (see section 2). In addition 
the recombinant protein was not glycosylated. Thus it is possi- 
ble, that the differences in the biological efficiency of the recom- 
binant rat C5a preparation from the native rat C5a [26] may 
also partially reflect sequence differences and the lack of glyco- 
sylation. However, differences in sequence and glycosylation 
probably play only a minor role, since recombinant rat C5a and 
native human C5a were almost equally potent in the release of 
N-acetyl-fl-D-glucosaminidase from human granulocytes (see 
below). 
3.2. Specificity of recomb&ant rat C5a-mediated formation & 
rat liver macrophages 
The increase in prostanoid formation by 0.1/.tg/ml recombi- 
nant rat C5a was inhibited by the neutralizing monoclonal 
antibody QD7, if recombinant rat C5a was incubated with a 
5-fold molar excess of the antibody 2 h prior to the experiment 
(Fig. 3). Incubation of C5a with buffer for the same period did 
not result in a loss of activity (not shown). The increase in 
prostanoid formation elicited by human C3a was not inhibited 
by QD7 (not shown). These results clearly indicate, that the 
action of recombinant rat C5a on Kupffer cells is due to a 
specific action of the peptide and cannot be attributed to a 
contamination with e.g. endotoxin. In addition, the endotoxin 
concentration i  the recombinant rat C5a preparation used was 
in the range of 1/.tg/ml. This would yield a concentration f 0.04 
flg/ml in the incubation mixture at the highest recombinant rat 
C5a concentration tested. This endotoxin concentration is far 
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Fig. 3. Specificity of prostanoid formation elicited by recombinant rat 
C5a in rat liver macrophages (A) and human granulocytes (13). (A) 
Kupffer cells were isolated and cultured as described in Fig. 1. Medium 
was replaced by Hanks buffered salt solution. Cells were stimulated 
with 0.1/lg recombinant rat C5a/ml (final concentration, rrC5a), that 
had been pre-incubated with a 5-fold molar excess of the neutralizing 
antibody QD7 for 2 h in a 500/~g/ml stock solution where indicated, 
or with 1/~g native human C5a/ml (nhC5a). After 10 min supernatants 
were removed and the increase in prostanoid concentration ver basal 
levels at 0 min, was determined by radioimmuno assay. Values are 
means + S.E.M. of 4 to 6 independent experiments. Statistics: Students 
t-test for paired samples *P < 0.01. (B) Freshly isolated human gran- 
ulocytes where stimulated with the concentration f native human C5a 
(nhC5a) or recombinant rat C5a (rrC5a) indicated and the release of 
N-acetyl-fl-D-glucosaminidase was determined in an optical test. Values 
represent arbitrary units of N-acetyl-fl-D-glucosaminidase activity de- 
termined in duplicate points in a single representative experiment. 
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Fig. 4. Increase in glycogen phosphorylase activity elicited by recombi- 
nant rat C5a in co-cultures of rat liver macrophages and rat hepato- 
cytes. Rat Kupffer cells were isolated and purified as described in Fig. 
1 and cultured in RPMI medium containing 30% newborn calf serum 
for 48 h on collagen coated tissue culture dishes. Then, hepatocytes that 
had been isolated by an EDTA perfusion and purified by percoll density 
gradient centrifugation, were seeded on top of the Kupffer cells or in 
separate culture dishes. Culture was continued for another 24 h. Where 
indicated, cells were incubated with 500 ,uM acetylsalicylic acid (ASA) 
for 30 min prior to the experiment. Medium was then removed and 
replaced by Hanks' balanced salt solution. Cells were stimulated by the 
addition of recombinant rat C5a (rrC5a, 1 Hg/ml), noradrenaline (NA, 
1 /IM) or native human C5a (nhC5a, 1 /zg/ml). Supernatants were 
removed and the increase in glycogen phosphorylase activity over basal 
levels was determined in the cell homogenates. Values are 
means + S.E.M. of the increase over basal activity in 4 or 5 independent 
experiments. Basal activities were: hepatocyte mono-cultures (HC) 
1.6 + 0.3 mU/mg hepatocyte DNA, hepatocyte/Kupffer c llco-cultures 
(HC/KC) 0.9 +_ 0.1 mU/mg hepatocyte DNA, assuming that 65% of the 
total DNA was due to hepatocytes [Hespeling, Jungermann, Piischel, 
unpublished observation]. Statistics: Student's t-test for paired samples: 
significantly greater than basal a: P < 0.01, b: P < 0.05; increase in 
glycogen phosphorylase activity in untreated co-cultures significantly 
greater than in acetyl salicylic acid treated cultures c: P < 0.05. 
below the concentration that has been described to increase 
prostanoid formation in rat Kupffer cells (100 ¢tg/ml) [9]. 
Native human C5a, in contrast o recombinant rat C5a, did 
not increase prostanoid formation in rat Kupffer cells even 
when added in concentrations up to 1 /zg/ml. Thus, native 
human C5a was not able to interact with C5a receptors on rat 
liver macrophages. In line with this hypothesis, native human 
C5a did not increase glycogenolysis in perfused rat liver [3]. By 
contrast, recombinant rat C5a and purified human C5a stimu- 
lated the release of N-acetyl-/3-D-glucosaminidase (NAGA) 
from human leukocytes almost equally well (Fig. 3). 
3.3. Stimulation by recombinant rat C5a of glycogen 
phosphorylase activity in hepatocyte/Kupffer c ll co-cultures 
In hepatocyte mono-cultures recombinant rat C5a increased 
glycogen phosphorylase activity only slightly by 1.25-fold 
(Fig. 4). This increase, though statistically not significant, might 
reflect the presence of C5a recptors in low density on hepato- 
cytes. The presence of a C5a receptor on hepatocytes would be 
in line with the recent demonstration f C5a receptors by in situ 
hybridization i  human liver and by binding studies on HepG2 
hepatoma cells [27]. 
In contrast o monocultures, recombinant rat C5a increased 
glycogen phosphorylase activity to a much larger extent, i.e. 
about 3-fold, in co-cultures of rat hepatocytes and Kupffer cells 
(Fig. 4). The difference between mono-cultures and co-cultures 
was abolished, if cultures were incubated with the irriversible 
inhibitor ofcyclooxygenase acetylsalicylic a id prior to stimula- 
tion with recombinant rat C5a. Thus, the increase in glycogen 
phosphorylase activity in co-cultures must have been largely 
mediated by the release of prostanoids from Kupffer cells. 
Prostanoids in turn can be directly activate glycogen phosphor- 
ylase in hepatocytes via a phospholipase C linked signal chain 
[7,8,10,11]. In line with this conclusion, the increase in glycogen 
phosphorylase activity by noradrenaline, which acts primarily 
directly on hepatocytes, was not attenuated by incubation with 
acetylsalicylic acid (Fig. 4). Native human C5a was inactive also 
in this system (Fig. 4). 
4. Conclusion 
C5a produced locally within the liver during regional inflam- 
matory processes or produced systemically during severe sepsis 
may increase glycogenolysis n hepatocytes and thus glucose 
output via an increase in prostanoid release from liver macro- 
phages, i.e. by intrahepatic ntercellular communication. A di- 
rect stimulation by C5a of glycogenolysis in hepatocytes may 
play, if any, only a minor role. 
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